Nucleic Acid Therapeutics Initiative
  • Organisation
  • Science
  • Accelerator
    • Funding Platform
    • Funding Opportunities
    • Portfolio
  • Careers
  • News & Events

Singapore launches Asia’s first automated mRNA manufacturing facility

4 November 2024 Read Full Article ↗
← Previous Article Speech by 2M Tan See Leng at MTI’s Committee of Supply Debate 2024
Next Article SCG Cell Therapy partners A*STAR to accelerate RNA-based therapeutic development in Singapore →
← Back to News
Email
LinkedIn
Nucleic Acid Therapeutics Initiative (NATi)
31 Biopolis Way, Nanos #09-01, Singapore 138669
© 2026 Nucleic Acid Therapeutics Initiative | Privacy Policy | Terms and Conditions
Nucleic Acid Therapeutics Initiative
Join OurMailing List